Pulsed magnetic field therapy for muscle loss from hormone treatment
Part of Cancer, Kidney & urinary clinical trials.
This study tests whether pulsed electromagnetic field therapy can help prevent or reverse muscle loss and weakness caused by hormone therapy (ADT) for prostate cancer. The treatment is non-invasive and may help you stay stronger during your cancer care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You have been diagnosed with prostate cancer that has not spread to other parts of the body.
- You have been on hormone therapy (ADT) for between six months and three years.
- You plan to continue hormone therapy for at least another six months.
- It has been at least four weeks since you had your prostate removed or finished radiation treatment.
- You are able to walk at least 400 meters (about a quarter mile) and are not currently getting radiation or other active cancer treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether doing strength training during hormone therapy can help your immune system fight prostate cancer better. It involves supervised exercise sessions alongside your usual treatment.
This study looks at how hormone therapy (ADT) affects muscle aging in older men with prostate cancer. It aims to understand why muscles weaken during this treatment, which could lead to better ways to protect muscle health in the future.
This study tests a new device that uses pulsed electric fields to destroy prostate cancer cells while healthy tissue is spared. It may help men with different stages of prostate cancer, and the study will see how safe and effective it is.
This study tests whether a supervised exercise program can help men with prostate cancer stay stronger and feel better during combined radiation and hormone therapy. You may be able to join if you are about to start these treatments and are otherwise healthy enough to exercise.
This trial tests a supervised exercise program to see if it can reduce frailty and muscle loss in men with metastatic prostate cancer who are on hormone therapy. It may help you become stronger and feel better during treatment.
This trial tests a structured resistance training program for men with prostate cancer who are on hormone therapy. The goal is to see if the exercise program helps maintain muscle strength and improve quality of life during treatment.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.